Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy OrganiGram stock | 1.13

Own OrganiGram stock in just a few minutes.


Fact checked

OrganiGram Holdings Inc is a drug manufacturers—specialty & generic business based in the US. OrganiGram shares (OGI) are listed on the NASDAQ and all prices are listed in US Dollars. OrganiGram employs 474 staff and has a market cap (total outstanding shares value) of USD$303 million.

How to buy shares in OrganiGram

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for OrganiGram. Find the stock by name or ticker symbol: OGI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OrganiGram reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.13, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of OrganiGram, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of OrganiGram. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted OrganiGram's share price?

Since the stock market crash in March caused by coronavirus, OrganiGram's share price has had significant negative movement.

Its last market close was USD$1.13, which is 57.84% down on its pre-crash value of USD$2.68 and 24.78% down on the lowest point reached during the March crash when the shares fell as low as USD$1.41.

If you had bought USD$1,000 worth of OrganiGram shares at the start of February 2020, those shares would have been worth USD$592.89 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$446.64.

OrganiGram share price

Use our graph to track the performance of OGI stocks over time.

OrganiGram shares at a glance

Information last updated 2020-11-30.
Latest market close USD$1.13
52-week range USD$1.01 - USD$3.47
50-day moving average USD$1.2415
200-day moving average USD$1.3913
Wall St. target price N/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.2589

Buy OrganiGram shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OrganiGram stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OrganiGram price performance over time

Historical closes compared with the close of $1.13 from 2020-11-16

1 week (2020-11-20) 0.89%
1 month (2020-10-30) -5.83%
3 months (2020-08-28) -11.72%
6 months (2020-05-28) -39.57%
1 year (2019-11-27) -58.15%
2 years (2018-11-28) -72.57%
3 years (2017-11-28) -59.06%
5 years (2015-11-27) 62.97%

OrganiGram financials

Gross profit TTM USD$48.5 million
Return on assets TTM -12.28%
Return on equity TTM -36.56%
Profit margin -145.16%
Book value N/A
Market capitalisation USD$303 million

TTM: trailing 12 months

Shorting OrganiGram shares

There are currently 14.3 million OrganiGram shares held short by investors – that's known as OrganiGram's "short interest". This figure is 2.7% down from 14.7 million last month.

There are a few different ways that this level of interest in shorting OrganiGram shares can be evaluated.

OrganiGram's "short interest ratio" (SIR)

OrganiGram's "short interest ratio" (SIR) is the quantity of OrganiGram shares currently shorted divided by the average quantity of OrganiGram shares traded daily (recently around 7.3 million). OrganiGram's SIR currently stands at 1.96. In other words for every 100,000 OrganiGram shares traded daily on the market, roughly 1960 shares are currently held short.

However OrganiGram's short interest can also be evaluated against the total number of OrganiGram shares, or, against the total number of tradable OrganiGram shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OrganiGram's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 OrganiGram shares in existence, roughly 60 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable OrganiGram shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against OrganiGram.

Find out more about how you can short OrganiGram stock.

OrganiGram share dividends

We're not expecting OrganiGram to pay a dividend over the next 12 months.

Have OrganiGram's shares ever split?

OrganiGram's shares were split on a 67:1 basis on 28 January 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 67 shares. This wouldn't directly have changed the overall worth of your OrganiGram shares – just the quantity. However, indirectly, the new 98.5% lower share price could have impacted the market appetite for OrganiGram shares which in turn could have impacted OrganiGram's share price.

OrganiGram share price volatility

Over the last 12 months, OrganiGram's shares have ranged in value from as little as $1.01 up to $3.47. A popular way to gauge a stock's volatility is its "beta".

OGI.US volatility(beta: 1.24)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OrganiGram's is 1.243. This would suggest that OrganiGram's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

OrganiGram overview

OrganiGram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, cannabis oils, and pre-rolls for adult recreational consumers under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trail Blazer brand names; and medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for the medical market. The company also engages in the wholesale shipping of medical cannabis plant cuttings and dried flowers. It sells its products through online, as well as telephone channels. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site